| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |